HaploX
PrivateLast Round
Series D
Jul 25, 2022
Est. Valuation
$430M
Total Funding Raised
$86.22M
Company Overview
HaploX is a biotechnology company that provides genetic testing solutions, specializing in gene sequencing, liquid biopsies, and bioinformatics for cancer diagnostics and health screening.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Hardware Sales, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HaploX Comparables
Compare HaploX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beijing Geneplus Technology | 93% | |
| 求臻医学 | 89% | |
| Geneseeq | 87% | |
HaploX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jul 25, 2022 | ||||
| Series C | Jul 1, 2021 | ||||
| Series B Extension | Apr 1, 2020 | ||||
| Series B | Jun 28, 2018 | ||||
| Series A Extension | Dec 28, 2017 | ||||
Series A | May 16, 2016 |
HaploX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Efung Capital | Series B |
| CNCB (Hong Kong) Investment Limited | Series D |
| SB China Capital | Series A Extension, Series D, Series A |
| Shenzhen Investment Holdings Co., Ltd. | Series B Extension |
| Mingjia Capital | Series C |
| Shenzhen Capital Group | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 28, 2017
$32M round with SB China Capital
HaploX Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about HaploX's valuation, stock price, and market status.